May. 19 at 11:37 PM
$SLS $SLS it is inevitable - the 80th Event PR is coming, Phase 3 Registrational Results and FDA Green light worth
$40B to big Pharma - are Coming.
ANY - DAY - NOW GPS P3 Results - truly worth
$40B + the Instant the REGAL Results are announced
- GPS MOS 30-36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the
$10B MCap Range /
$50 Per Share - AND CLIMBING
And to Bottom LINE 009 - its worth
$27 Per Share Right Now / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value. -- Gleevic - Imatinib, Imbrutinib -- Imbruvica, -- Upadactinib -- Rinvoq Upadactinib <- say that 3 x fast
$PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor
Novartis' Kisqali -Ribociclib CDKinase Inhibitor
$LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor
$SLS Tambiciclib CDKInase Inhibitor
reddit.com/r/sellasLifescience ... for anyone interested in DD/ i been here -invested a long time/ if you have an interest in $